iothalamic acid has been researched along with Dyslipidemias in 1 studies
Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Approximately 24-40% of patients with type 2 diabetes mellitus (T2DM) develop kidney damage." | 1.43 | Early intensive treatment improves outcomes in patients with glomerular hyperfiltration and type 2 diabetes. ( Bonal, J; Bonet, J; Romero, R; Salinas, I; Sanmartí, A; Torres, F; Troya, MI, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Troya, MI | 1 |
| Bonet, J | 1 |
| Salinas, I | 1 |
| Torres, F | 1 |
| Bonal, J | 1 |
| Sanmartí, A | 1 |
| Romero, R | 1 |
1 other study available for iothalamic acid and Dyslipidemias
| Article | Year |
|---|---|
Early intensive treatment improves outcomes in patients with glomerular hyperfiltration and type 2 diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Cardiovascular Disease | 2016 |